Wells Fargo analyst Ike Boruchow maintains Hanesbrands (NYSE:HBI) with a Overweight and lowers the price target from $18 to $13.
EF Hutton Maintains Buy on Nanoviricides, Lowers Price Target to $5.25
EF Hutton analyst Constantine Davides maintains Nanoviricides (AMEX:NNVC) with a Buy and lowers the price target from $8.5 to $5.25.